Ausgabe 3-4/2007
Inhalt (17 Artikel)
Energy metabolism in brain cells: effects of elevated ammonia concentrations
Leif Hertz, Geeta Kala
New concepts in the mechanism of ammonia-induced astrocyte swelling
M. D. Norenberg, A. R. Jayakumar, K. V. Rama Rao, K. S. Panickar
The anaplerotic flux and ammonia detoxification in hepatic encephalopathy
Claudia Zwingmann
Aquaporins in the brain: from aqueduct to “multi-duct”
Jérôme Badaut, Jean-François Brunet, Luca Regli
New findings on cerebral ammonia uptake in HE using functional 13N-ammonia PET
Michael Sørensen, Susanne Keiding
Controversies in ammonia metabolism: implications for hepatic encephalopathy
Alan H. Lockwood
The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy
Samir Ahboucha, Roger F. Butterworth
NMDA receptors in hyperammonemia and hepatic encephalopathy
Marta Llansola, Regina Rodrigo, Pilar Monfort, Carmina Montoliu, Elena Kosenko, Omar Cauli, Blanca Piedrafita, Nisrin El Mlili, Vicente Felipo
Tryptophan, adenosine, neurodegeneration and neuroprotection
T. W. Stone, C. M. Forrest, G. M. Mackay, N. Stoy, L. G. Darlington
Caecal ligation and puncture in the rat mimics the pathophysiological changes in human sepsis and causes multi-organ dysfunction
H. F. Brooks, C. K. Osabutey, R. F. Moss, P. L. R. Andrews, D. C. Davies
Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension
Gavin Wright, Debbie Shawcross, Steven W. M. Olde Damink, Rajiv Jalan
The treatment of hepatic encephalopathy
Marsha Y. Morgan, A. Blei, K. Grüngreiff, R. Jalan, G. Kircheis, G. Marchesini, O. Riggio, Karin Weissenborn
Therapeutic studies in hepatic encephalopathy
Kevin D. Mullen, Piero Amodio, Marsha Y. Morgan
Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA
Chih-Ming Lin, Peterus Thajeb